EC Healthcare (02138) released its Environmental, Social and Governance Report for the year ended 31 March 2026, detailing operational progress across environmental, social and governance pillars.
Environmental Performance • Greenhouse-gas (GHG) emissions rose to 4,102 tonnes CO2e (FY2025: 3,709 tonnes), driven mainly by higher electricity demand from expanded diagnostic services. Scope 2 electricity-related emissions accounted for 4,027 tonnes CO2e. • Electricity consumption increased to 9.35 million kWh (FY2025: 7.83 million kWh) as the Group ramped up medical imaging capacity; intensity was 15.57 kWh per square foot. • Water use totalled 13,832 m³, broadly stable year on year, while hazardous and non-hazardous waste reached 8.75 tonnes and 16.55 tonnes respectively. • Ongoing mitigation measures include phased installation of IoT-enabled energy-management systems, double low-e glazing at a new medical building in Tsim Sha Tsui, an electronic reimbursement platform to curb paper waste, and Hong Kong’s first paperless imaging centre.
Social Highlights • Customer-centric metrics remained strong with a 99.99% satisfaction rate and a 63.2% repurchase rate. • Average training hours per employee climbed 16% to 25.9 hours; occupational-health and risk-management content was added to onboarding programmes. • Diversity targets advanced: women hold 55% of senior-management and department-head positions. • Community outreach reached over 4,000 beneficiaries and 50 residential care homes, offering vaccination drives, vision-care days and osteoarthritis support. • Two management-talent pipelines—the Management Trainee and Relationship Executive programmes—continued to develop future leaders.
Governance and Financing • The nine-member Board comprises 33% independent non-executive directors and oversees ESG through a dedicated Sustainability Committee and Working Group. • A Medical Advisory Board chaired by former Secretary for Food and Health Dr Ko Wing Man reviews governance, risk mitigation and clinical quality on a quarterly basis. • The Group’s risk-management framework aligns with ISO 31000:2018; quality controls underpin nine licensed Day Procedure Centres and ISO 15189-accredited laboratories. • EC Healthcare remains the first Hong Kong healthcare operator to secure sustainability-linked financing, raising HK$700 million in 2022 and expanding the facility to HK$1.00 billion in 2023, with 100% of performance targets met for two consecutive years.
Operations Snapshot • The Group manages 148 service points under more than 40 medical and wellness brands across Greater China, including the market-leading DR REBORN aesthetic chain.
Looking to 2030, EC Healthcare targets full rollout of energy-efficient lighting and IoT systems, water-saving installations in new facilities, comprehensive waste-management practices, continued annual growth in employee training hours and volunteer engagement, and expanded Board involvement in ESG oversight.
Comments